SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-234365
Filing Date
2017-07-25
Accepted
2017-07-25 06:06:05
Documents
2
Period of Report
2017-07-18
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d419003d8k.htm 8-K 16397
2 EX-3.1 d419003dex31.htm EX-3.1 258524
  Complete submission text file 0001193125-17-234365.txt   276040
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 17979253
SIC: 2836 Biological Products, (No Diagnostic Substances)